Ghana vs United States: Cases started on MDR-TB treatment
Ghana
186
in 2024
United States
175
in 2023
Ghana rank
50th
United States rank
53rd
Cases started on MDR-TB treatment over time
- Ghana
- United States
How they compare
Ghana currently reports 186 against 175 in United States, a difference of 11.
That makes Ghana's figure about 1.1 times United States's.
The two have swapped places 1 time across 15 shared years of data; in 2008 it was United States ahead.
Ghana ranks 50th and United States ranks 53rd of 193 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and United States in 2.
Head to head by decade
| Decade | Ghana | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 64 | 64 | United States |
| 2010s | 68.33 | 103.11 | 34.78 | United States |
| 2020s | 200.75 | 109.75 | 91 | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Ghana or United States?
- Ghana, at 186 against 175 in United States as of 2024.
- What is the difference in cases started on mdr-tb treatment between Ghana and United States?
- 11, with Ghana ahead.
- How many years of comparable data are there for Ghana and United States?
- 15 years are reported by both, from 2008 to 2023.
- How do Ghana and United States rank globally for cases started on mdr-tb treatment?
- Ghana ranks 50th and United States ranks 53rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.